Publicaciones (46) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A new host-targeted antiviral cyclolignan (SAU-22.107) for Dengue Virus infection in cell cultures. Potential action mechanisms based on cell imaging

    Virus Research, Vol. 323

  2. Antileishmanial Activity and In Silico Molecular Docking Studies of Malachra alceifolia Jacq. Fractions against Leishmania mexicana Amastigotes

    Tropical Medicine and Infectious Disease, Vol. 8, Núm. 2

  3. Antiplasmodial activity, structure-activity relationship and studies on the action of novel benzimidazole derivatives

    Scientific reports, Vol. 13, Núm. 1, pp. 285

  4. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis

    CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320

  5. Computational Structural Revision of Elaeophorbate and Other Triterpenoids with the Help of NAPROC-13. A New Strategy for Structural Revision of Natural Products

    Journal of Natural Products, Vol. 86, Núm. 4, pp. 897-908

  6. Detección de síntomas asociados a trastornos depresivos desde la farmacia comunitaria

    Ars pharmaceutica, Vol. 64, Núm. 1, pp. 80-80

  7. Diseño y desarrollo de una crema pañal con leche de burra

    Farmajournal, Vol. 8, Núm. 1, pp. 21-31

  8. Efectos adversos de la interacción triple whammy detectados en un servicio de urgencias hospitalario

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 35, Núm. 5, pp. 394-396

  9. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  10. El reto formativo en enfermedades infecciosas: análisis de los Másteres Oficiales en España

    REDU: Revista de Docencia Universitaria, Vol. 21, Núm. 2

  11. Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles

    Cancers, Vol. 15, Núm. 12

  12. Evaluation of Two Osmosis-Based Methods for the Preparation of Drug Delivery Systems Based on Red Blood Cells

    Pharmaceutics, Vol. 15, Núm. 9

  13. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  14. Formulación y optimización de nanopartículas lipídicas con chitosán para la administración de quercetina

    Farmajournal, Vol. 8, Núm. 2, pp. 17-25

  15. Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  16. GuaB3, an overlooked enzyme in cyanobacteria's toolbox that sheds light on IMP dehydrogenase evolution

    Structure, Vol. 31, Núm. 12, pp. 1526-1534.e4

  17. Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series

    Journal of Crohn's and Colitis, Vol. 17, Núm. 5, pp. 722-727

  18. Importancia de las interacciones alimentos-medicamentos. Propuesta de un procedimiento de trabajo dentro del Servicio de Seguimiento Farmacoterapéutico

    Ars pharmaceutica, Vol. 64, Núm. 1, pp. 40-40

  19. Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells

    Pharmaceutics, Vol. 15, Núm. 3

  20. In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis

    European Journal of Medicinal Chemistry, Vol. 258